about
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its pro...
Read More
0.38
0.01
(2.70%)
559.4K
XNAS Volume
High vol.+gain this week
XNAS 15 Jul, 2025 3:57 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..